SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer

Nagpal, Chitrakshi ; Sharma, Atul ; Bakhshi, Sameer ; Malik, Prabhat Singh ; Gupta, Hardik ; Mittal, Chetanya ; Gund, Sneha ; Kumar, Akash ; Sharma, Aparna ; Pushpam, Deepam ; Khurana, Sachin ; Pramanik, Raja ; Gupta, Nishkarsh ; Batra, Atul (2024) SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer JCO Global Oncology (10). ISSN 2687-8941

Full text not available from this repository.

Official URL: https://doi.org/10.1200/GO.23.00447

Related URL: http://dx.doi.org/10.1200/GO.23.00447

Abstract

Purpose Serial patient-reported outcome (PRO) measurements in clinical practice are associated with a better quality of life and survival. Recording electronic PROs using smartphones is an efficient way to implement this. We aimed to assess the feasibility of the electronically filled Edmonton Symptom Assessment System (e-ESAS) scale in the lower-middle–income country (LMIC) setting. Methods Baseline clinical features and conventional paper-based ESAS (p-ESAS) were collected in newly diagnosed patients with solid organ tumors. Text message link was sent to these patients for filling e-ESAS. ESAS was categorized into physical, psychological, and total symptom domains. Scores were divided into none to mild (0-3) and moderate to severe (4-10). Intraclass correlation coefficients (ICCs) were used to determine the correlation between p-ESAS and e-ESAS. Multivariable logistic regression was used to identify independent factors affecting symptom burden. Results Of 1,160 participants who filled out p-ESAS, 595 completed both e-ESAS and p-ESAS questionnaires and were included in the final analysis. Moderate to severe physical, psychological, and total symptom scores were seen in 39.8%, 40%, and 39% of participants. Tiredness and anxiety were the most common physical and psychological symptoms, respectively. ICCs between the p-ESAS and e-ESAS varied between 0.75 and 0.9. Total symptom scores were independently predicted by metastatic disease (odds ratio [OR], 1.83; 95% CI, 1.26 to 2.67; P = .001) and a higher level of education (OR, 0.42; 95% CI, 0.25 to 0.72; P = .001). Conclusion Paper-based and electronically filled ESASs have good intraobserver reliability across individual symptoms and domain scores in a representative cohort at a tertiary care institute in the LMIC. This may help us incorporate e-ESAS in routine clinical care in the real-world setting with financial, infrastructural, and manpower limitations.

Item Type:Article
Source:Copyright of this article belongs to American Society of Clinical Oncology.
ID Code:138415
Deposited On:20 Aug 2025 06:34
Last Modified:20 Aug 2025 06:34

Repository Staff Only: item control page